Presented as a pale yellow crystalline powder with good solubility in ethanol and chloroform, it supports flexible oral dosage form development. It caters to the core needs of anti-inflammatory drug manufacturers, rheumatology therapy developers, and cardiovascular pharmaceutical suppliers. Widely applied in gout flare management, familial Mediterranean fever treatment, and ASCVD secondary prevention, it aligns with demand for multi-indication anti-inflammatory raw materials. Produced under strict GMP standards, each batch undergoes rigorous purity, stability, and bioactivity testing to meet international pharmacopoeia requirements, ensuring consistency for clinical use.
